Page 109 - Neuropsychiatric.indd
P. 109

45. St Louis EK, Gidal BE, Henry TR, Kaydanova Y, Krumholz A, McCabe PH, et al. Conversions
                   between monotherapies in epilepsy: expert consensus. Epilepsy Behav. 2007;11(2):222-

                   34.
               46. Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol.
                   2014;77(2):295-301.
               47. Baclofen. [accessed 10 January 2021]. Available from: https://reference.medscape.com/

                   drug/lioresal-baclofen-343335
               48. Khoury R, Ghossoub E. Antipsychotics and seizures: What are the risks? Current Psychiatry.
                   2019;18(3):21-33.

               49. Wong J, Delva N. Clozapine-induced seizures: recognition and treatment. Can J Psychiatry.
                   2007;52(7):457-63.
               50. Bora I, Demir AB, Uzun P. Nonconvulsive status epilepticus cases arising in connection with
                   cephalosporins. Epilepsy Behav Case Rep. 2016;20(6):23-7.
               51. Krzeminski P, Lesiak A, Narbutt J. Seizures as a rare adverse effect of chloroquine therapy

                   in systemic lupus erythematosus patients: a case report and literature survey. Postepy
                   Dermatol Alergol. 2018;35(4):429-30.
               52. McDonald WM. Overview of neurocognitive disorders. Focus (Am Psychiatr Publ).

                   2017;15(1):4-12.
               53. Splinter MY. Chapter 17 Cognitive disorder. In: Tisdale JE et al., eds. Drug-Induced Diseases:
                   Prevention, Detection,  and Management. 3rd  ed.  United  States:  American  Society of
                   Health-System Pharmacists, Inc., 2018.

               54. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence,
                   prevention and management. Drug Saf. 1999;21(2):101-22.
               55. Fuller MA. Chapter 15 Delirium. In: Tisdale JE et al., eds. Drug-Induced Diseases: Prevention,
                   Detection, and Management. 3rd ed. United States: American Society of Health-System

                   Pharmacists, Inc., 2018.
               56. Stoner SC. Drug induced cognitive dysfunction. Medical update for psychiatrists. 1997;
                   2(3):81-5.
               57. Bowen JD, Larson EB. Drug-induced cognitive impairment. Defining the problem and finding

                   solutions. Drugs Aging 1993;3(4):349-57.
               58. Baldez DP, Biazus TB, Rabelo-da-Ponte FD, Nogaro GP, Martins DS, Kunz M, et al. The effect
                   of antipsychotics on the cognitive performance of individuals with psychotic disorders:
                   network meta-analyses of  randomized  controlled  trials. Neurosci  Biobehav  Rev.

                   2021;126:265-75.
               59. Wingo AP, Wingo TS, Harvey PD, Baldessarini RJ. Effects of lithium on cognitive
                   performance: a meta-analysis. J Clin Psychiatry. 2009;70(11):1588-97.







                                                                                                        88
               88
   104   105   106   107   108   109   110   111   112   113   114